0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Human Health Effects Policy & Risk Reproductive & Development Sign in to save

Microplastics in Humans: A Critical Review of Biomonitoring Evidence and Immune–Metabolic Associations

Applied Sciences 2025 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count.
Dominika Kusyk, Ilona Górna, Magdalena Kowalówka, Michalina Banaszak, Karol Jakubowski, Sławomira Drzymała-Czyż

Summary

This review critically evaluates the current evidence on microplastic detection in human tissues and biological fluids, focusing on methodological challenges and the potential biological mechanisms of action. Researchers found significant variation across studies due to differences in analytical techniques and sample handling protocols. The study highlights emerging evidence linking microplastic presence in the body to immune and metabolic disruptions, while noting that standardized detection methods are urgently needed.

Microplastics in the human body pose a significant health challenge due to their potential impact on the immune system and metabolic processes. This review summarises and critically evaluates current evidence regarding the detection of microplastics in human tissues and biological fluids, as well as their potential biological mechanisms of action. Published studies were examined with particular attention to methodological diversity, analytical techniques, and differences in study design. The review highlights consistent observations of microplastic presence in human organs, including the placenta, blood, and lungs, while also revealing significant variability in detection methods and exposure assessment. Evidence suggests that microplastics may have a potential impact on immune functions, including the modulation of the immune response, the risk of autoimmunity and immunosuppression, and metabolic homeostasis disorders that affect hormone regulation, glucose, and lipid levels. Despite the growing number of studies, major gaps include the lack of standardised analytical protocols, limited long-term human data, and insufficient mechanistic understanding at the molecular level. Addressing these gaps is crucial for enhancing risk assessment and developing effective preventive strategies to minimise human exposure to microplastics and safeguard public health.

Share this paper